Ramipril Capsule
Product Images NDC 76282-673

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 76282-673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Exelan Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem-structure.jpg (Chem Structure)

Chemical structure of Ramipril shown as a detailed 2D molecular diagram with labeled bonds, rings, and functional groups, including an ethyl ester (EtOOC) and carboxylic acid (COOH) group.*

FDA Label Image

Image 01

Ramipril Capsules USP 1.25 mg oral capsules label by Exelan Pharmaceuticals, Inc. The label includes dosage strength of 1.25 mg and states each capsule contains 1.25 mg ramipril USP. Packaging details show this unit contains 100 capsules. Additional text advises storage at 20° to 25°C and keeping out of reach of children.*

FDA Label Image

Image 02

Ramipril Capsules USP 2.5 mg oral capsules manufactured for Exelan Pharmaceuticals, Inc. The label indicates a package containing 100 capsules. It includes storage instructions, dosage guidance referencing the package insert, and identifies West-Ward Columbus Inc. as the manufacturer. The NDC code 76282-671-01 and a barcode are also visible.*

FDA Label Image

Image 03

Label for Ramipril Capsules USP 5 mg by Exelan Pharmaceuticals, Inc. The label states each capsule contains 5 mg ramipril USP. It includes storage instructions to keep at 20° to 25°C and to keep out of reach of children. The label shows a 100 capsule package and includes the NDC number 76282-672-01.*

FDA Label Image

Image 04

Label for Ramipril Capsules USP 10 mg, an oral capsule prescription drug by Exelan Pharmaceuticals, Inc. The label states each capsule contains 10 mg ramipril and the package contains 100 capsules. Additional text includes storage instructions to keep between 20° to 25°C, dosage directions referring to package insert, and manufacturer information for Exelan Pharmaceuticals and West-Ward Columbus Inc.*

FDA Label Image

Image 05

A line graph comparing the proportion of patients over days of follow-up between Ramipril and a placebo. The x-axis represents days of follow-up up to around 1800 days, and the y-axis shows the proportion of patients up to 0.20. Two lines are shown: a solid line for Ramipril and a dashed line for placebo, with the placebo line consistently higher. A p-value of 0.0001 is displayed indicating statistical significance.*

FDA Label Image

Image 06

A forest plot chart depicting the relative risk of composite outcomes in various patient subgroups treated with Ramipril versus placebo. It includes subgroups such as cardiovascular disease presence, diabetes status, age, sex, hypertension, history of coronary artery disease, prior myocardial infarction, cerebrovascular disease, peripheral vascular disease, and microalbuminuria, showing number of patients, incidence rates in placebo groups, and confidence intervals for relative risks in the Ramipril group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.